Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
about
sameAs
Mycobacterium avium subspecies paratuberculosis, Crohn's disease and the Doomsday scenarioPrimary treatment of Crohn’s disease: combined antibiotics taking center stageReview of inflammatory bowel disease in ChinaMycobacterium paratuberculosis as a cause of Crohn's diseaseOn the action of cyclosporine A, rapamycin and tacrolimus on M. avium including subspecies paratuberculosisCurrent status of Mycobacterium avium subspecies paratuberculosis infection in animals & humans in India: What needs to be done?Cell wall-deficient bacteria as a cause of infections: a review of the clinical significance.Infectious etiopathogenesis of Crohn's diseaseAntibacterial and antimycobacterial treatment for inflammatory bowel disease.Inflammatory bowel disease: new insights into pathogenesis and treatment.Treatment of refractory Crohn's disease and pyoderma gangrenosum with a combination regimen of rifaximin, gentamicin and metronidazoleDetection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease.High prevalence of Mycobacterium avium subspecies paratuberculosis IS900 DNA in gut tissues from individuals with Crohn's diseaseSuccessful treatment of asymptomatic or clinically terminal bovine Mycobacterium avium subspecies paratuberculosis infection (Johne's disease) with the bacterium Dietzia used as a probiotic alone or in combination with dexamethasone: Adaption to chrAnti-inflammatory activity of ansamycins.Use of antibiotics in the treatment of inflammatory bowel disease.Variable responses of formyl peptide receptor haplotypes toward bacterial peptides.The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease.Analysis of bacterial bowel communities of IBD patients: what has it revealed?Monensin causes dose dependent inhibition of Mycobacterium avium subspecies paratuberculosis in radiometric cultureReview paper: modulation of mononuclear phagocyte function by Mycobacterium avium subsp. paratuberculosis.Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use.Crohn's disease and the mycobacterioses: a quarter century later. Causation or simple association?Mycobacterium avium subspecies paratuberculosis in the etiology of Crohn's disease, cause or epiphenomenon?Histologic scoring indices for evaluation of disease activity in Crohn's disease.The alternate effects of anti-TNFα therapeutics and their role in mycobacterial granulomatous infection in Crohn's disease.Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.A single capsule formulation of RHB-104 demonstrates higher anti-microbial growth potency for effective treatment of Crohn's disease associated with Mycobacterium avium subspecies paratuberculosisRHB-104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn's disease associated with Mycobacterium paratuberculosis.Concurrent Resolution of Chronic Diarrhea Likely Due to Crohn's Disease and Infection with Mycobacterium avium paratuberculosis.Suspected intestinal tuberculosis might be Crohn's disease."In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis.A Potential 'Curative' Modality for Crohn's Disease---Modeled after Prophylaxis of Bovine Johne's Disease.The study of gastric mucosa for possible bacterial causative agent of Crohn's disease.The Consensus from the Mycobacterium avium ssp. paratuberculosis (MAP) Conference 2017Severe recurrent Crohn's disease of ileocolonic anastomosis and antimicrobial (anti-mycobacterial) therapy.Correlation between rpoB gene mutation in Mycobacterium avium subspecies paratuberculosis and clinical rifabutin and rifampicin resistance for treatment of Crohn's disease.The C-Type Lectin Mincle: Clues for a Role in Crohn's Disease Adjuvant Reaction.Fecal detection of Mycobacterium avium paratuberculosis using the IS900 DNA sequence in Crohn's disease and ulcerative colitis patients and healthy subjects
P2860
Q21092926-BEFBBB58-926F-46F6-B2CE-F34C01F296F5Q22241483-74C128F4-0A9E-42A7-A875-076C184B0E99Q27009485-022D190E-2DAB-4E9F-8B3B-7EF9965BBF71Q28081602-01C6EFF1-612D-4D5D-AD40-653918D6F393Q33346257-1FA8DBCB-682E-4926-9DED-5BC811207803Q33568847-4F200364-1310-4ED9-B229-31E1BC278145Q33984369-A0F49236-E8F6-4B00-91C4-250C55331C79Q34168490-1464C536-4AB1-43B1-93D7-8629F73A3060Q34399158-77B07984-A343-4120-A057-D69FE03E5341Q35020743-C0790567-9F73-4DB4-B55B-1828CB4CE84DQ35127966-77F15AEE-0D6F-4148-B0D2-E92385EB4CEEQ35155665-67141329-EB28-4E94-9CD9-E615E6A6A065Q35597642-CAB6CA73-1A0C-469D-8590-C304A86090D1Q35693684-84981A07-2476-4BC9-81E9-BC865A18C15FQ36066223-E93A45A4-E1E2-4283-AE9D-CB4EE5BBB9B8Q36521201-CB8D9D23-FFF4-436A-B4FE-BDC5A1890B41Q36732572-70BB5FA4-0F34-4888-B366-B6F1F6A964CAQ36751990-9D584BF3-67C3-4D1B-B079-BB11B69334B1Q37084765-7299C3E0-AA69-4DD3-9C21-CC6191684B81Q37147704-24759335-878F-4C42-B18E-A1D3206A128CQ37317741-F4AB2F32-CDB7-4030-BB83-1B58AEF8D810Q37723798-4941B1BB-DF2F-4618-A174-682DF4B41B0CQ37975540-E5D7F02A-D3E1-4D00-ABD0-5FDF662BFCA7Q38256340-13148A0F-BADE-4387-A042-9485A477DAC2Q38668188-B1D11357-D4A9-45BE-99CE-F2E30956CB34Q38686563-CE3A2D37-9D49-42B9-AF9D-96F1A8502C28Q38727911-02704DE7-B5AD-4B85-8CB9-62916582ECC5Q39318255-8646DD13-7DC5-4990-AC91-FA38B905FF9CQ39679682-0C85DFA9-E0B3-4788-B440-7D6102B43FF2Q40456700-F951A6F4-7205-4C26-AACF-28361CBBD56CQ40658357-59229EEF-741F-4BA4-9358-0BEF142F8DF4Q41503375-4EE6D7C8-EE39-4582-8CF9-45D060FDF76EQ41905099-A5A77D01-4E43-4A34-9091-A8CD3257742CQ42115878-A19F3149-A4EF-4DBA-966B-DD45AD389307Q42288751-6BC62AFE-F0F9-490D-8767-5EEFA3E4756DQ42844479-32A2CF4C-E28A-455D-9C12-2071F4F4963CQ43096293-D5C5E572-1DF1-4E06-A992-CDA8FFCB37AFQ46318718-6CFC78D6-C161-4EF8-B61E-36EF9B7B9E33Q56984269-F1AA9C62-670B-45CE-A606-C4A219A147BE
P2860
Treatment of severe Crohn's disease using antimycobacterial triple therapy--approaching a cure?
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@ast
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@en
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@nl
type
label
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@ast
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@en
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@nl
prefLabel
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@ast
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@en
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@nl
P2093
P3181
P1476
Treatment of severe Crohn's di ...... e therapy--approaching a cure?
@en
P2093
P3181
P356
10.1016/S1590-8658(02)80056-1
P407
P577
2002-01-01T00:00:00Z